Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Chronic Rhinosinusitis with Nasal Polyps and Asthma
Tanya M Laidlaw1, Joaquim Mullol2, Katharine M Woessner3
1Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma share type 2 inflammation. Systemic biologic therapies targeting these pathways offer new treatment options for severe, difficult-to-manage respiratory conditions.
Area of Science:
- Immunology
- Otolaryngology
- Pulmonology
Background:
- Chronic rhinosinusitis with nasal polyps (CRSwNP) often involves a type 2 immune signature, leading to severe and recurrent disease.
- Asthma frequently co-occurs with CRSwNP, sharing similar underlying pathophysiology, tissue eosinophilia, and elevated local IgE levels.
- The comorbidity of CRSwNP and asthma results in more severe sinonasal symptoms, reduced quality of life, and treatment resistance in both conditions.
Purpose of the Study:
- To highlight the shared type 2 inflammatory pathways in CRSwNP and comorbid asthma.
- To emphasize the clinical challenges and severity associated with CRSwNP in patients with asthma, including Aspirin/nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (AERD).
- To advocate for a unified approach to managing upper and lower airway diseases by targeting common inflammatory mechanisms.
Main Methods:
- Review of existing literature on CRSwNP, asthma, and their shared inflammatory pathways.
- Analysis of clinical characteristics and treatment challenges in patients with comorbid CRSwNP and asthma.
- Exploration of the rationale for systemic biologic therapies targeting type 2 inflammation.
Main Results:
- CRSwNP with asthma exhibits significant tissue eosinophilia and high local IgE, contributing to disease severity.
- Aspirin/nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (AERD) represents a severe phenotype of CRSwNP with asthma, characterized by difficult-to-treat polyps and inflammation.
- The interconnected pathophysiology necessitates a systemic treatment approach, moving beyond isolated management of nasal and lung conditions.
Conclusions:
- The shared type 2 inflammation in CRSwNP and asthma underscores the need for integrated management strategies.
- Systemic biologic treatments targeting shared type 2 inflammatory pathways present a promising therapeutic avenue for severe CRSwNP with comorbid asthma.
- Recognizing the systemic link between upper and lower airway inflammation is crucial for improving patient outcomes.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
Related Concept Videos
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation